New Horizons in Nephrology - Glomerular Disease Webinar 2026: Addressing the B-Cell Dysregulation in Glomerular Diseases

LIVECMEConferences & Symposia
New Horizons in Nephrology - Glomerular Disease Webinar 2026: Addressing the B-Cell Dysregulation in Glomerular Diseases Banner

Add to Calendar New Horizons in Nephrology - Glomerular Disease Webinar 2026: Addressing the B-Cell Dysregulation in Glomerular Diseases 2/26/2026 5:00:00 PM 2/26/2026 8:00:00 PM America/New_York For More Details: https://upenn.cloud-cme.com/GlomerularDiseaseWebinar2026 Description: B cells play a central role in the pathogenesis of many glomerular diseases through antibody production, antigen presentation, and cytokine release that drive renal inflammation and injury. Diseases such as lupus nephritis, membranous nephropathy, IgA nephropathy, and ANCA-associated vasculitis are characterized by pathogenic autoantibodies or immune complex deposition, underscoring B cells as key therape... Virtual Meeting false MM/DD/YYYY


Date & Location
Thursday, February 26, 2026, 5:00 PM - 8:00 PM, Virtual Meeting

Course Overview
B cells play a central role in the pathogenesis of many glomerular diseases through antibody production, antigen presentation, and cytokine release that drive renal inflammation and injury. Diseases such as lupus nephritis, membranous nephropathy, IgA nephropathy, and ANCA-associated vasculitis are characterized by pathogenic autoantibodies or immune complex deposition, underscoring B cells as key therapeutic targets. Advances in our understanding of B-cell biology have led to the development of novel treatment strategies, including monoclonal antibodies targeting CD20 (rituximab, obinutuzumab), CD19, and BAFF/APRIL signaling pathways. These therapies aim to modulate B-cell activity, reduce pathogenic antibody production, and achieve sustained disease remission with fewer side effects compared to traditional immunosuppression. Given the rapidly expanding landscape of B-cell–directed therapies and their emerging indications in glomerular diseases, it is critical for clinicians to understand their mechanisms, efficacy data, and safety considerations to optimize patient outcomes.

Target Audience
Specialties - INTERNAL MEDICINE - Nephrology

Learning Objectives

After completing this activity, participants should be able to:


  1. Discuss the role of B-cells in kidney disease pathogenesis
  2. Evaluate the efficacy and safety of existing and emerging B-cell targeted therapies in inducing and maintaining remission and preventing relapses
  3. Define best practices for B-cell targeted therapies

Registration

VIRTUAL PRESENTATIONS
New Horizons in Nephrology - Glomerular Disease Webinar 2026: Addressing the B-Cell Dysregulation in Glomerular Diseases will be held Friday, February 26, 2026.

REGISTRATION FEES (LIVE-STREAM/VIRTUAL ATTENDANCE)
The fee to attend virtually is $50. All registrants will receive conference information and the link to join the live broadcast via email 48 hours in advance of the meeting. All pre-registered virtual attendees will receive an email that includes a link with instructions to sign-in and join the virtual conference 48 hours preceding the conference.


Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

DESIGNATION OF CREDIT
Physicians: Penn Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PA’s may receive a maximum of 3.0 Category 1 credits for completing this activity.


Credits
AMA PRA Category 1 Credits™ (3.00 hours), Non-Physician Attendance / Participation (3.00 hours)

Additional Information

CANCELLATION AND REFUND POLICY
In order to process refunds for course withdrawals, cancellations must be received via email by February 23, 2026. Please email [email protected] or [email protected] regarding cancellations.

The University of Pennsylvania reserves the right to cancel or postpone this course due to unforeseen circumstances. In the event of a cancellation or postponement, the University will refund registration fees but is not responsible for fees assessed for travel or hotels.